BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17454757)

  • 1. D-dimer identifies stages in the progression of diabetes mellitus from family history of diabetes to cardiovascular complications.
    Nwose EU; Richards RS; Jelinek HF; Kerr PG
    Pathology; 2007 Apr; 39(2):252-7. PubMed ID: 17454757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes exacerbates angiographic coronary lesion progression in subjects with metabolic syndrome independent of CRP levels.
    Liang KW; Lee WJ; Lee WL; Chen YT; Ting CT; Sheu WH
    Clin Chim Acta; 2008 Feb; 388(1-2):41-5. PubMed ID: 17967444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes: assessment of endothelial lesion and fibrinolytic system markers.
    Soares AL; Sousa Mde O; Dusse LM; Fernandes AP; Lasmar MC; Novelli BA; Lages Gde F; Carvalho Md
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):395-9. PubMed ID: 17581312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma D-dimer concentration in patients with systemic sclerosis.
    Marie I; Borg JY; Hellot MF; Levesque H
    Br J Dermatol; 2008 Feb; 158(2):392-5. PubMed ID: 18028493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
    Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
    Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
    Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative damage indices for the assessment of subclinical diabetic macrovascular complications.
    Nwose EU; Richards RS; Kerr RG; Tinley R; Jelinek H
    Br J Biomed Sci; 2008; 65(3):136-41. PubMed ID: 18986101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the erythrocyte glutathione concentration in the course of diabetes mellitus.
    Nwose EU; Jelinek HF; Richards RS; Kerr PG
    Redox Rep; 2006; 11(3):99-104. PubMed ID: 16805963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic changes and clinical sequelae after on-pump compared with off-pump coronary artery bypass surgery: a prospective randomized study.
    Paulitsch FS; Schneider D; Sobel BE; Rached R; Ramires J; Jatene F; Stolf N; Hueb W; Lopes NH
    Coron Artery Dis; 2009 Mar; 20(2):100-5. PubMed ID: 19293667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent elevation of fibrin D-dimer predicts longterm outcome in systemic juvenile idiopathic arthritis.
    Bloom BJ; Alario AJ; Miller LC
    J Rheumatol; 2009 Feb; 36(2):422-6. PubMed ID: 19040298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin D-dimer and cardiovascular risk.
    Lowe GD
    Semin Vasc Med; 2005 Nov; 5(4):387-98. PubMed ID: 16302161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of vital exhaustion and depressive symptoms with changes in fibrin D-dimer to acute psychosocial stress.
    von Känel R; Bellingrath S; Kudielka BM
    J Psychosom Res; 2009 Jul; 67(1):93-101. PubMed ID: 19539823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherothrombosis and oxidative stress: the connection and correlation in diabetes.
    Nwose EU; Jelinek HF; Richards RS; Tinley P; Kerr PG
    Redox Rep; 2009; 14(2):55-60. PubMed ID: 19389272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical probability assessment and D-dimer determination in patients with suspected deep vein thrombosis, a prospective multicenter management study.
    Elf JL; Strandberg K; Nilsson C; Svensson PJ
    Thromb Res; 2009 Feb; 123(4):612-6. PubMed ID: 18514263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitral regurgitation reduces systemic coagulation activity in patients with rheumatic heart disease.
    Cevik C; Otahbachi M; Nugent K; Ozkan M
    J Heart Valve Dis; 2009 May; 18(3):278-83. PubMed ID: 19557983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weil's disease with elevated plasma D-dimer.
    Ohnishi K; Kato Y; Hayakawa K
    Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):154-6. PubMed ID: 16771228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study.
    Legnani C; Palareti G; Cosmi B; Cini M; Tosetto A; Tripodi A;
    Haematologica; 2008 Jun; 93(6):900-7. PubMed ID: 18443269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of plasma D-dimer levels in patients with colorectal cancer.
    Kilic M; Yoldas O; Keskek M; Ertan T; Tez M; Gocmen E; Koc M
    Colorectal Dis; 2008 Mar; 10(3):238-41. PubMed ID: 17868411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.